|
Donkalnis1
|
HGN |
Mesolithic |
Lithuania |
F |
-5500 |
-2900 |
U5b1 |
fasta
|
0.05
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
|
Donkalnis4
|
HGN |
Mesolithic |
Lithuania |
M |
-6000 |
-5740 |
U5b2c1 |
fasta
|
0.02
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
|
Donkalnis6
|
HGN |
Mesolithic |
Lithuania |
F |
-4720 |
-4530 |
U5a2e |
fasta
|
6.03
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
|
Donkalnis7
|
HGN |
Mesolithic |
Lithuania |
M |
-5460 |
-4940 |
U5a2d1 |
fasta
|
0.76
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
|
Gyvakarai1
|
CWC |
Neolithic |
Lithuania |
M |
-2690 |
-2470 |
K1b2a |
fasta
|
7.56
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
146C (MT-CR): Absence of Endometriosis (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
5913A (MT-CO1): Prostate Cancer / hypertension (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
|
Kivisaare3
|
NEBL |
Neolithic |
Estonia |
M |
-4730 |
-4540 |
U4a1 |
fasta
|
0.19
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15693C (MT-CYB): Possibly LVNC cardiomyopathy-associated (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
499A (MT-CR): Endometriosis (Reported)
|
|
Kivutkalns153
|
BABL |
Bronze Age |
Latvia |
M |
-800 |
-545 |
U5a1a1 |
fasta
|
0.33
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15924G (MT-TT): LIMM (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
|
Kivutkalns164
|
BABL |
Bronze Age |
Latvia |
M |
-730 |
-390 |
U5a2a1 |
fasta
|
0.09
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
|
Kivutkalns19
|
BABL |
Bronze Age |
Latvia |
M |
-730 |
-400 |
H10a |
fasta
|
5.76
|
|
FASTA
Metadata
|
|
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
|
|
Kivutkalns194
|
BABL |
Bronze Age |
Latvia |
M |
-800 |
-545 |
T1a1b |
fasta
|
0.15
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
|
|
Kivutkalns207
|
BABL |
Bronze Age |
Latvia |
F |
-730 |
-390 |
H1b2 |
fasta
|
7.21
|
|
FASTA
Metadata
|
|
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
|
|
Kivutkalns209
|
BABL |
Bronze Age |
Latvia |
M |
-450 |
-230 |
J1b1a1 |
fasta
|
2.24
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
16093C (MT-CR): Cyclic Vomiting Syndrome (Reported)
-
295T (MT-CR): Low VO2max response (Reported)
-
2158C (MT-RNR2): Reduced risk PD (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
462T (MT-CR): Low VO2max response (Reported)
-
489C (MT-CR): Low VO2max response (Reported)
-
5460A (MT-ND2): AD / PD / LHON (Conflicting reports)
|
|
Kivutkalns215
|
BABL |
Bronze Age |
Latvia |
F |
-790 |
-535 |
H1c |
fasta
|
2.73
|
|
FASTA
Metadata
|
|
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
|
|
Kivutkalns222
|
BABL |
Bronze Age |
Latvia |
M |
-805 |
-515 |
U5a1c1 |
fasta
|
1.28
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
|
|
Kivutkalns25
|
BABL |
Bronze Age |
Latvia |
M |
-800 |
-545 |
H28a |
fasta
|
1.57
|
|
FASTA
Metadata
|
|
-
146C (MT-CR): Absence of Endometriosis (Reported)
|
|
Kivutkalns42
|
BABL |
Bronze Age |
Latvia |
F |
-810 |
-560 |
H1b1 |
fasta
|
1.10
|
|
FASTA
Metadata
|
|
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
3796G (MT-ND1): Adult-Onset Dystonia (Reported)
-
9861C (MT-CO3): AD (Reported)
|
|
Kretuonas1
|
NEBL |
Neolithic |
Lithuania |
F |
-4460 |
-3820 |
U5b1 |
fasta
|
0.37
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
|
Kretuonas2
|
NEBL |
Neolithic |
Lithuania |
M |
-5500 |
-2900 |
U5b2b |
fasta
|
1.28
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
12634G (MT-ND5): Thyroid Cancer Cell Line (Reported)
-
13637G (MT-ND5): Possible LHON factor (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16270T (MT-CR): Melanoma patients (Reported)
|
|
Kretuonas4
|
NEBL |
Neolithic |
Lithuania |
F |
-5500 |
-2900 |
U5b1b1a |
fasta
|
8.79
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
-
3391A (MT-ND1): LHON (Reported)
|
|
Kretuonas5
|
NEBL |
Neolithic |
Lithuania |
M |
-4450 |
-4340 |
U5b2b |
fasta
|
0.20
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
12634G (MT-ND5): Thyroid Cancer Cell Line (Reported)
-
13637G (MT-ND5): Possible LHON factor (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16270T (MT-CR): Melanoma patients (Reported)
|
|
Motala1913
|
HGN |
Mesolithic |
Sweden |
F |
-5722 |
-5564 |
U5a2d |
<NA>
|
0.05
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16093C (MT-CR): Cyclic Vomiting Syndrome (Reported)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
|
Olsund
|
NESC |
Neolithic |
Sweden |
M |
-2573 |
-2140 |
U4c2a |
fasta
|
2.22
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15693C (MT-CYB): Possibly LVNC cardiomyopathy-associated (Reported)
-
499A (MT-CR): Endometriosis (Reported)
|
|
Plinkaigalis241
|
CWC |
Neolithic |
Lithuania |
F |
-2860 |
-2410 |
I2 |
fasta
|
0.21
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
12705T (MT-CO1): Possible protective factor for normal tension glaucoma (Reported)
-
15043A (MT-CYB): MDD-associated (Reported)
-
15924G (MT-TT): LIMM (Reported)
|
|
Plinkaigalis242
|
CWC |
Neolithic |
Lithuania |
F |
-3260 |
-2630 |
W6a |
fasta
|
2.57
|
|
FASTA
Metadata
|
|
-
12705T (MT-CO1): Possible protective factor for normal tension glaucoma (Reported)
-
16192T (MT-CR): Melanoma patients (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
5460A (MT-ND2): AD / PD / LHON (Conflicting reports)
|
|
Popovo2
|
HGN |
Mesolithic |
Russia |
M |
-7500 |
-5000 |
U4d |
fasta
|
0.06
|
|
FASTA
Metadata
|
|
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15693C (MT-CYB): Possibly LVNC cardiomyopathy-associated (Reported)
-
16093C (MT-CR): Cyclic Vomiting Syndrome (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
499A (MT-CR): Endometriosis (Reported)
|
|
Saxtorp5164
|
FBC |
Neolithic |
Sweden |
F |
-3945 |
-3647 |
T2b |
fasta
|
0.59
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
|
|
Spiginas1
|
NESC |
Neolithic |
Lithuania |
M |
-4440 |
-4240 |
H11a |
fasta
|
6.11
|
|
FASTA
Metadata
|
|
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
961G (MT-RNR1): Possibly DEAF-associated (Unclear)
|
|
Spiginas2
|
CWC |
Neolithic |
Lithuania |
M |
-2130 |
-1750 |
I4a |
fasta
|
3.16
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
12705T (MT-CO1): Possible protective factor for normal tension glaucoma (Reported)
-
15043A (MT-CYB): MDD-associated (Reported)
-
15924G (MT-TT): LIMM (Reported)
-
16129A (MT-CR): Cyclic Vomiting Syndrome with Migraine (Reported)
-
8519A (MT-ATP8): Susceptibility to bullous pemphigoid (Reported)
|
|
Spiginas4
|
HGN |
Mesolithic |
Lithuania |
F |
-6440 |
-6230 |
U4a2 |
fasta
|
1.12
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
15693C (MT-CYB): Possibly LVNC cardiomyopathy-associated (Reported)
-
499A (MT-CR): Endometriosis (Reported)
|
|
Tamula1
|
NEBL |
Neolithic |
Estonia |
F |
-3630 |
-3360 |
U5a1d2b |
fasta
|
0.17
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
|
Tamula3
|
NEBL |
Neolithic |
Estonia |
F |
-3800 |
-3640 |
U4d2 |
fasta
|
0.16
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
12662G (MT-ND5): Recurrent pregnancy loss (Reported)
-
15693C (MT-CYB): Possibly LVNC cardiomyopathy-associated (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
499A (MT-CR): Endometriosis (Reported)
-
5567C (MT-TW): Myopathy (Reported)
|
|
Turlojiske1932
|
TRC |
Bronze Age |
Lithuania |
F |
-1230 |
-920 |
U5a2a1 |
fasta
|
0.08
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
|
Turlojiske1
|
TRC |
Bronze Age |
Lithuania |
M |
-930 |
-810 |
T2b |
fasta
|
0.13
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
|
|
Turlojiske5
|
TRC |
Bronze Age |
Lithuania |
M |
-2100 |
-600 |
H5 |
fasta
|
0.06
|
|
FASTA
Metadata
|
|
|
|
Turlojiske3
|
TRC |
Bronze Age |
Lithuania |
M |
-1010 |
-800 |
H4a1a1a3 |
fasta
|
0.67
|
|
FASTA
Metadata
|
|
-
10044G (MT-TG): SIDS (Unclear)
-
14582G (MT-ND6): LHON synergistic combo 14258A + 14582G (Reported: individually neutral variants causing LHON in combination)
|
|
UzOO77
|
HGN |
Mesolithic |
Russia |
F |
-5500 |
-5000 |
R1b |
fasta
|
0.73
|
|
FASTA
Metadata
|
|
-
1095C (MT-RNR1): SNHL (Unclear)
-
1391C (MT-RNR1): found in 1 HCM patient (Reported)
-
146C (MT-CR): Absence of Endometriosis (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
|
|
Veibri4
|
NEBL |
Neolithic |
Estonia |
F |
-4900 |
-4720 |
U5b1 |
fasta
|
1.05
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|